Shield Therapeutics plc announced that Jose A. Menoyo, M.D., is joining Shield's Senior Executive Team as Vice President and Chief Medical Officer with immediate effect. Prior to joining Shield, Dr. Menoyo served as Head of US Medical Affairs at Alexion Pharmaceuticals Inc. (Alexion) acquired by AstraZeneca in July 2021. In this role, Dr. Menoyo led the Medical Affairs and Health Outcomes and Research teams that supported several launches in the rare disease area. Prior to his role at Alexion, Dr. Menoyo was the Sr. Vice-President of Clinical Development and Medical Affairs for ZS Pharma, which was eventually acquired by AstraZeneca. Dr. Menoyo completed his Internal Medicine and Nephrology Fellowship at Hahnemann University Hospital and Medical College of Pennsylvania and will be reporting to Greg Madison, CEO. The company also confirms that further to the announcement issued on 28 May 2021, Tim Watts will resign from the Board with effect from 30 September 2021 and no longer have any role with the Group from that date.